Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch

被引:23
作者
Wang, Xin [1 ]
Gou, Xiaoli [2 ]
Yu, Xiaojuan [2 ]
Bai, Dongdong [2 ]
Tan, Bowei [2 ]
Cao, Pingfeng [2 ]
Qian, Meilin [2 ]
Zheng, Xiaoxiao [2 ]
Wang, Hairong [2 ]
Tang, Pingming [2 ]
Zhang, Chen [2 ]
Ye, Fei [2 ]
Ni, Jia [2 ]
机构
[1] Xinjiang Med Univ, Intens Care Unit, Affiliated Hosp 1, Urumqi, Peoples R China
[2] Haisco Pharmaceut Grp Co Ltd, Ctr Drug Res & Dev, Chegdu, Peoples R China
关键词
HSK21542; kappa opioid receptor; pain; pruritus; animal models; CHRONIC CONSTRICTION INJURY; PROTEIN-BIASED LIGAND; QUANTITATIVE ASSESSMENT; SUBSTANTIA-GELATINOSA; SCRATCHING BEHAVIOR; NEUROPATHIC PAIN; RAT MODEL; MU; NALFURAFINE; RESPONSES;
D O I
10.3389/fphar.2021.773204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kappa opioid receptor (KOR) agonists have been promising therapeutic candidates, owing to their potential for relieving pain and treating intractable pruritus. Although lacking morphine-like central nervous system (CNS) effects, KOR agonists do elicit sedation, dysphoria and diuresis which seriously impede their development. Peripherally-restricted KOR agonists have a poor ability to penetrate into the CNS system, so that CNS-related adverse effects can be ameliorated or even abolished. However, the only approved peripherally-restricted KOR agonist CR845 remains some frequent CNS adverse events. In the present study, we aim to address pharmacological profiles of HSK21542, with an expectation to provide a safe and effective alternative for patients who are suffering from pain and pruritus. The in vitro experimental results showed that HSK21542 was a selective and potent KOR agonist with higher potency than CR845, and had a brain/plasma concentration ratio of 0.001, indicating its peripheral selectivity. In animal models of pain, HSK21542 significantly inhibited acetic acid-, hindpaw incision- or chronic constriction injury-induced pain-related behaviors, and the efficacy was comparable to CR845 at 15 min post-dosing. HSK21542 had a long-lasting analgesic potency with a median effective dose of 1.48 mg/kg at 24 h post-drug in writhing test. Meanwhile, the antinociceptive activity of HSK21542 was effectively reversed by a KOR antagonist nor-binaltorphimine. In addition, HSK21542 had powerful antipruritic activities in compound 48/80-induced itch model. On the other hand, HSK21542 had a weak ability to produce central antinociceptive effects in a hot-plate test and fewer effects on the locomotor activity of mice. HSK21542 didn't affect the respiratory rate of mice. Therefore, HSK21542 might be a safe and effective KOR agonist and promising candidate for treating pain and pruritus.
引用
收藏
页数:13
相关论文
共 56 条
[1]   Antinociceptive effects of Teucrium polium L. total extract and essential oil in mouse writhing test [J].
Abdollahi, M ;
Karimpour, H ;
Monsef-Esfehani, HR .
PHARMACOLOGICAL RESEARCH, 2003, 48 (01) :31-35
[2]   Transient loss of terminals from non-peptidergic nociceptive fibers in the substantia gelatinosa of spinal cord following chronic constriction injury of the sciatic nerve [J].
Bailey, AL ;
Ribeiro-da-Silva, A .
NEUROSCIENCE, 2006, 138 (02) :675-690
[3]   Sciatic chronic constriction injury produces cell-type-specific changes in the electrophysiological properties of rat substantia gelatinosa neurons [J].
Balasubramanyan, Sridhar ;
Stemkowski, Patrick L. ;
Stebbing, Martin J. ;
Smith, Peter A. .
JOURNAL OF NEUROPHYSIOLOGY, 2006, 96 (02) :579-590
[4]   A PHARMACOLOGICAL PROFILE OF THE NOVEL, PERIPHERALLY-SELECTIVE KAPPA-OPIOID RECEPTOR AGONIST, EMD-61753 [J].
BARBER, A ;
BARTOSZYK, GD ;
BENDER, HM ;
GOTTSCHLICH, R ;
GREINER, HE ;
HARTING, J ;
MAULER, F ;
MINCK, KO ;
MURRAY, RD ;
SIMON, M ;
SEYFRIED, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1317-1327
[5]   A PERIPHERAL MONONEUROPATHY IN RAT THAT PRODUCES DISORDERS OF PAIN SENSATION LIKE THOSE SEEN IN MAN [J].
BENNETT, GJ ;
XIE, YK .
PAIN, 1988, 33 (01) :87-107
[6]   Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain [J].
Biddlestone, L. ;
Corbett, A. D. ;
Dolan, S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (02) :285-291
[7]   Analgesic and antiinflammatory effects of two novel κ-opioid peptides [J].
Binder, W ;
Machelska, H ;
Mousa, S ;
Schmitt, T ;
Rivière, PJM ;
Junien, JL ;
Stein, C ;
Schäfer, M .
ANESTHESIOLOGY, 2001, 94 (06) :1034-1044
[8]  
Bishop K., 2015, 8 WORLD C ITCH WCI
[9]   Synthesis and Pharmacological Evaluation of 5-Pyrrolidinylquinoxalines as a Novel Class of Peripherally Restricted κ-Opioid Receptor Agonists [J].
Bourgeois, Christian ;
Werfel, Elena ;
Galla, Fabian ;
Lehmkuhl, Kirstin ;
Torres-Gomez, Hector ;
Schepmann, Dirk ;
Koegel, Babette ;
Christoph, Thomas ;
Strassburger, Wolfgang ;
Englberger, Werner ;
Soeberdt, Michael ;
Huewel, Sabine ;
Galla, Hans-Joachim ;
Wuensch, Bernhard .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) :6845-6860
[10]   Characterization of a rat model of incisional pain [J].
Brennan, TJ ;
Vandermeulen, EP ;
Gebhart, GF .
PAIN, 1996, 64 (03) :493-501